Practical guide for evaluation and management of beta-lactam allergy: position statement from the Canadian Society of Allergy and Clinical Immunology
Samira Jeimy, Moshe Ben‐Shoshan, Elissa M. Abrams, Anne K. Ellis, Lori Connors, Tiffany Wong
Abstract
The vast majority of individuals labelled as allergic are not deemed truly allergic upon appropriate assessment by an allergist. A label of beta-lactam allergy carries important risks for individual and public health. This article provides an overview of beta-lactam allergy, implications of erroneous beta-lactam allergy labels and the impact that can be provided by structured allergy assessment. We provide recommendations on how to stratify risk of beta-lactam allergy, beta lactam challenge protocols as well as management of patients at high risk of beta-lactam allergy.
Topics & Concepts
AllergyBeta-lactamMedicinePosition statementImmunologyClinical immunologyIntensive care medicineFamily medicineAntibioticsBiologyMicrobiologyDrug-Induced Adverse ReactionsPharmaceutical studies and practicesAsthma and respiratory diseases